rs375891337
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_012452.3(TNFRSF13B):c.716C>T(p.Ala239Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,606,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. A239A) has been classified as Likely benign.
Frequency
Consequence
NM_012452.3 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency, common variable, 2Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen, G2P, Ambry Genetics
- common variable immunodeficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012452.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFRSF13B | NM_012452.3 | MANE Select | c.716C>T | p.Ala239Val | missense | Exon 5 of 5 | NP_036584.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TNFRSF13B | ENST00000261652.7 | TSL:1 MANE Select | c.716C>T | p.Ala239Val | missense | Exon 5 of 5 | ENSP00000261652.2 | ||
| TNFRSF13B | ENST00000583789.1 | TSL:1 | c.578C>T | p.Ala193Val | missense | Exon 4 of 4 | ENSP00000462952.1 | ||
| TNFRSF13B | ENST00000579009.1 | TSL:6 | n.1350C>T | non_coding_transcript_exon | Exon 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152210Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000818 AC: 2AN: 244548 AF XY: 0.00000756 show subpopulations
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1454092Hom.: 0 Cov.: 35 AF XY: 0.0000111 AC XY: 8AN XY: 722074 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 2 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 239 of the TNFRSF13B protein (p.Ala239Val). This variant is present in population databases (rs375891337, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TNFRSF13B-related conditions. ClinVar contains an entry for this variant (Variation ID: 471370). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at